Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, et al. Alternative donor transplantation after reduced intensity conditioning: Results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood. 2011;118:282–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ruggeri A, Sanz G, Bittencourt H, Sanz J, Rambaldi A, Volt F, et al. Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia working party of EBMT. Leukemia. 2014;28:779–86.

Article  PubMed  CAS  Google Scholar 

Ruggeri A, Labopin M, Sanz G, Piemontese S, Arcese W, Bacigalupo A, et al. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. Leukemia. 2015;29:1891–1900.

Article  PubMed  CAS  Google Scholar 

Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122:491–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhu X, Tang B, Sun Z. Umbilical cord blood transplantation: Still growing and improving. Stem Cells Transl Med. 2021;10:S62–74.

Article  PubMed  PubMed Central  Google Scholar 

Yanada M, Takami A, Yamasaki S, Arai Y, Konuma T, Uchida N, et al. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century. Ann Hematol. 2020;99:1351–60.

Article  PubMed  Google Scholar 

Gratwohl A, Baldomero H, Passweg J, Urbano-Ispizua A, Baur A, Elvy P, et al. Increasing used of reduced intensity conditioning transplants: Report of the 2001 EBMT activity survey. Bone Marrow Transpl. 2002;30:813–31.

Article  CAS  Google Scholar 

Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, et al. Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol. 2017;35:1154–61.

Article  PubMed  PubMed Central  Google Scholar 

Feinstein L, Sandmaier B, Maloney D, McSweeney PA, Maris M, Flowers C et al. Nonmyeloablative hematopoietic cell transplantation: Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect. Ann N Y Acad Sci. 2001;938:328–37.

Mcsweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood. 2001;97:3390–400.

Article  PubMed  CAS  Google Scholar 

Giralt S, Khouri I, Champlin R. Non myeloablative ‘mini transplants’. Cancer Treat Res. 1999;101:97–108.

Article  PubMed  CAS  Google Scholar 

Bacigalupo A. Special report Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT). Bone Marrow Transpl. 2002;29:191–5.

Article  CAS  Google Scholar 

Barrett J, Childs R. Non-myeloablative stem cell transplant. Br J Haematol. 2000;111:6–17.

PubMed  CAS  Google Scholar 

Rio B, Chevret S, Vigouroux S, Chevallier P, Fürst S, Sirvent A, et al. Decreased Nonrelapse Mortality after Unrelated Cord Blood Transplantation for Acute Myeloid Leukemia Using Reduced-Intensity Conditioning: A Prospective Phase II Multicenter Trial. Biol Blood Marrow Transplant. 2015;21:445–53.

Article  PubMed  Google Scholar 

Oran B, Wagner JE, DeFor TE, Weisdorf DJ, Brunstein CG. Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2011;17:1327–34.

Article  PubMed  PubMed Central  Google Scholar 

Sheth V, Volt F, Sanz J, Clement L, Cornelissen J, Blaise D, et al. Cord Blood Reduced-Intensity versus Myeloablative Conditioning in Cord Blood Transplantation for Acute Myeloid Leukemia (40-60 years) across Highly Mismatched HLA Barriers-On Behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT Biology of Blood and Marrow Transplantation. Biol Blood Marrow Transpl. 2020;26:2098–104.

Article  CAS  Google Scholar 

Baron F, Ruggeri A, Beohou E, Labopin M, Sanz G, Milpied N, et al. RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT. Oncotarget. 2016;7:43027–38.

Article  PubMed  PubMed Central  Google Scholar 

Salit RB, Oliver DC, Delaney C, Sorror ML, Milano F. Prognostic Value of the Hematopoietic Cell Transplantation Comorbidity Index for Patients Undergoing Reduced-Intensity Conditioning Cord Blood Transplantation. Biol Blood Marrow Transplant. 2017;23:654–8.

Article  PubMed  Google Scholar 

Ringdén O, Labopin M, Ehninger G, Niederwieser D, Olsson R, Basara N, et al. Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia. J Clin Oncol. 2009;27:4570–7.

Article  PubMed  Google Scholar 

Shimoni A, Labopin M, Savani B, Volin L, Ehninger G, Kuball J, et al. Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation. J Hematol Oncol. 2016;9:1–10.

Article  Google Scholar 

Akahoshi Y, Tada Y, Sakaida E, Kusuda M, Doki N, Uchida N, et al. Novel risk assessment for the intensity of conditioning regimen in older patients. Blood Adv. 2023;7:4738–47.

Article  PubMed  CAS  Google Scholar 

Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2009;15:367–9.

Article  PubMed  PubMed Central  Google Scholar 

Przepiorka D. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow TransplantMID: 7581076. 1995;15:825–8.

CAS  Google Scholar 

Sullivan KM. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28:250–9.

PubMed  CAS  Google Scholar 

Oken MM. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.

Article  PubMed  CAS  Google Scholar 

Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Atsuta Y, Kanda J, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, et al. Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia. Haematologica. 2013;98:814–22.

Article  PubMed  PubMed Central  Google Scholar 

Cheson BD, Bennett JM, Kopecky KJ, Büchner T, Willman CL, Estey EH, et al. Revised Recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol. 2003;21:4642–9.

Article  PubMed  Google Scholar 

Fine JP, & GRJ. A Proportional Hazards Model for the Subdistribution of a Competing Risk. J Am Stat Assoc. 1999;94:496–509.

Article  Google Scholar 

Lewis S. Clarke M. Forest plots: trying to see the wood and the trees. BMJ. 2001;16:1479–80.

Article  Google Scholar 

Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, et al. Cord-Blood Transplantation in Patients with Minimal Residual Disease. N. Engl J Med. 2016;375:944–53.

Article  PubMed  PubMed Central  Google Scholar 

Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia. N. Engl J Med. 2004;351:2276–85.

Article  PubMed  CAS  Google Scholar 

Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang M-J, Champlin RE, et al. Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia. N. Engl J Med. 2004;351:2265–75.

Article  PubMed